Applying advanced psychometric approaches yields differential randomized trial effect sizes: secondary analysis of individual participant data from antidepressant studies using the Hamilton rating scale for depression
This study aimed to determine if using advanced psychometrics methods would inform any clinically or statistically important differences in clinical trial outcomes when compared to original findings. We applied factor analysis (FA), item response theory (IRT), and network analysis (NA) to the most commonly used measure of depression in clinical settings - the Hamilton Rating Scale for Depression (HRSD) - to identify and remove nonperforming survey items and calculate weighted item scores. We found that the efficacy reported in trials increased when using FA to removed items, but decreased when using NA. There was almost no change in efficacy when using IRT. Using weighted scores based on respective models offered no additional utility in terms of increasing or decreasing efficacy outcomes.
Authors
- David Hevey (ORCID: https://orcid.org/0000-0003-2844-0449)
- Susan Brannick
- David F. Byrne (ORCID: https://orcid.org/0000-0002-0587-4677)
- Pim J. Cuijpers (ORCID: https://orcid.org/0000-0001-5497-2743)
- Robert M. Carney (ORCID: https://orcid.org/0000-0002-0737-6655)
- Emma K. Wallace (ORCID: https://orcid.org/0000-0002-9315-2956)
- Kenneth E. Freedland (ORCID: https://orcid.org/0000-0002-3118-9913)
- Suzanne Guérin (ORCID: https://orcid.org/0000-0002-6744-7590)
- Bishember Kathuria
- Frank Doyle (ORCID: https://orcid.org/0000-0002-3785-7433)
- Fiona Boland (ORCID: https://orcid.org/0000-0003-3228-0046)
- Alexandra Lelia Dima (ORCID: https://orcid.org/0000-0002-3106-2242)
Institutions
- University College Dublin (IE)
- Mercy Medical Center (US)
- Washington University in St. Louis (US)
- Trinity College Dublin (IE)
- University College Cork (IE)
- Sant Joan de Déu Research Foundation (ES)
- Novartis (Ireland) (IE)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Journal of Clinical Epidemiology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1016/j.jclinepi.2025.111762
- Citations
- 3
- Primary Topic
- Mental Health Research Topics
- Type
- article
- Field-Weighted Citation Impact
- 6.35
Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Irish Research Council